Your browser doesn't support javascript.
loading
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
Molyneaux, Philip L; Fahy, William A; Byrne, Adam J; Braybrooke, Rebecca; Saunders, Peter; Toshner, Richard; Albers, Gesa; Chua, Felix; Renzoni, Elisabetta A; Wells, Athol U; Karkera, Yakshitha; Oballa, Eunice; Saini, Gauri; Nicholson, Andrew G; Jenkins, R Gisli; Maher, Toby M.
Affiliation
  • Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Fahy WA; Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Byrne AJ; Discovery Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
  • Braybrooke R; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Saunders P; Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Toshner R; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Albers G; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Chua F; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Renzoni EA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Wells AU; Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Karkera Y; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Oballa E; Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Saini G; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Nicholson AG; Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Jenkins RG; Biostatistics, GlaxoSmithKline R&D, Bangalore, India; and.
  • Maher TM; Discovery Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
Am J Respir Crit Care Med ; 205(12): 1440-1448, 2022 06 15.
Article in En | MEDLINE | ID: mdl-35363592
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2022 Document type: Article Affiliation country: